A carregar...
Anti-c-Met monoclonal antibody ABT-700 breaks oncogene addiction in tumors with MET amplification
BACKGROUND: c-Met is the receptor tyrosine kinase for hepatocyte growth factor (HGF) encoded by the MET proto-oncogene. Aberrant activation of c-Met resulting from MET amplification and c-Met overexpression is associated with poor clinical outcome in multiple malignancies underscoring the importance...
Na minha lista:
Publicado no: | BMC Cancer |
---|---|
Main Authors: | , , , , , , , , , , , , , , , , , |
Formato: | Artigo |
Idioma: | Inglês |
Publicado em: |
BioMed Central
2016
|
Assuntos: | |
Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4755020/ https://ncbi.nlm.nih.gov/pubmed/26879245 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-016-2138-z |
Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|